Work

Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies.

Year: 2001

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: M L Tetef, T W Synold, W Chow, L Leong, K Margolin, R Morgan, J Raschko, S Shibata, G Somlo, Y Yen, S Groshen, K Johnson, H J Lenz, D Gandara, J H Doroshow

Institution: City Of Hope National Medical Center

Language: English

Topic: Chemotherapy-induced cardiotoxicity and mitigation

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

Awards: Phase I Molecular and Clincal Pharmacodynamic Trials, Cancer Center Support Grant

OpenAlex ID: W2162796038

FWCI: 2.039

Cites: 30

Cited by: 22

Related to: 10